https://gbdeclaration.org/"The Declaration was written from a global public health and humanitarian perspective, with special
concerns about how the current COVID-19 strategies are forcing our children, the working class and the poor to carry the heaviest burden. The response to the pandemic in many countries around the world, focused on lockdowns, contact tracing and isolation,
imposes enormous unnecessary health costs on people. In the long run,
it will lead to higher COVID and non-COVID mortality than the focused protection plan we call for in the Declaration. "
"Dr. Kulldorff works on research grants from the National Institutes of Health, the Centers for Disease Control and Prevention, the Food and Drug Administration and the non-profit Fund for Public Health in New York City, some of which is related to COVID-19. He has never accepted or received any funding from pharmaceutical companies, nor from any other large corporation.
Dr. Bhattacharya research funding over the past 22 years of his career has come almost entirely from grants from the National Institutes of Health, the National Science Foundation, the US Department of Agriculture, and participation on contracts with the Center for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) via a government contracting research group, Acumen, LLC. He has never accepted or received any funding from pharmaceutical companies, nor from any other large corporation.
Dr. Gupta’s research funding over the last 30 years has principally been through fellowships and investigator awards from the Wellcome Trust and the European Research Council. She has also received funding from the UKRI, the Royal Society, the Leverhulme Trust, the Emily and Georg von Opel Foundation and the Oxford Martin School. She and Dr. Craig Thompson have developed a novel method for producing a universal influenza vaccine (derived from a mathematical model) and this has now been licensed and is going through early testing. She does not hold any consultancy contracts or stock shares in any commercial company."